BiotechTube

Test Product + Reference Product + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bronchial Asthma

Conditions

Bronchial Asthma

Trial Timeline

Mar 12, 2019 → Dec 20, 2019

NCT ID
NCT04051710

About Test Product + Reference Product + Placebo

Test Product + Reference Product + Placebo is a phase 3 stage product being developed by Aurobindo Pharma for Bronchial Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT04051710. Target conditions include Bronchial Asthma.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04051710Phase 3Completed

Competing Products

20 competing products in Bronchial Asthma

See all competitors
ProductCompanyStageHype Score
TacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 2
52
Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) + Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1 + Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2 + PlaceboCiplaPhase 3
77
90 mcg Reference Product + 180 mcg Reference Product + 90 mcg Test Product + PlaceboCiplaPhase 3
77
Fluticasone propionate/salmeterol 100/50 µg + Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUATCiplaPhase 3
77
Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Reference) + Albuterol Sulfate HFA 0.09 mg (Test) + Albuterol Sulfate HFA 0.18 mg (Test) + PlaceboAurobindo PharmaPhase 3
77
Fluticasone propionate Inhalation Aerosol 44 mcg + FLOVENT HFA 44 mcg + Matching Placebo inhalerGlenmark PharmaceuticalsPhase 3
77
Symbicort Turbuhaler + Symbicort pMDI + Pulmicort TurbuhalerAstraZenecaPhase 3
77
RoflumilastAstraZenecaPhase 3
77
RoflumilastAstraZenecaPhase 2/3
65
Symbicort (budesonide/formoterol) Turbuhaler + Conventional treatmentAstraZenecaPhase 3
77
CiclesonideAstraZenecaPhase 3
77
Montelukast plus prednisolone + PrednisoloneMerckPhase 2
52
MontelukastMerckApproved
85
Formoterol fumerate + fenoterol/ipratropium bromideNovartisApproved
85
inhaled corticosteroid therapyNovartisPhase 1/2
41
PF-00610355 + PF - 00610355 + PF - 00610355PfizerPhase 2
51
NivolumabBristol Myers SquibbPhase 2
51
HSK31858 + PlaceboHaisco Pharmaceutical GroupPhase 2
49
HSK31858 + PlaceboHaisco Pharmaceutical GroupPhase 2
49

Other Products from Aurobindo Pharma

Adapalene 0.1% Gel + Differin 0.1% Topical GelPhase 3
77
Albuterol Sulfate HFA 0.09 mg (Reference) + Albuterol Sulfate HFA 0.18 mg (Reference) + Albuterol Sulfate HFA 0.09 mg (Test) + Albuterol Sulfate HFA 0.18 mg (Test) + PlaceboPhase 3
77
Amphotericin B Liposome + AmBisome (Amphotericin B) LiposomePhase 1
33
Amlodipine - reference + Amlodipine ODT - test + Amlodipine ODT - testPhase 1
33
Amlodipine - reference + Amlodipine ODT - testPhase 1
33